Methylene-bridged selective androgen receptor modulators and methods of use thereof

Details for Australian Patent Application No. 2003287077 (hide)

Owner University of Tennessee Research Foundation

Inventors Dalton, James T.; Miller, Duane D.

Agent Griffith Hack

Pub. Number AU-B-2003287077

PCT Number PCT/US2003/0325

PCT Pub. Number WO2004/035738

Priority 60/418,166 15.10.02 US

Filing date 14 October 2003

Wipo publication date 4 May 2004

Acceptance publication date 20 September 2007

International Classifications

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

Event Publications

1 April 2004 Complete Application Filed

  Priority application(s): 60/418,166 15.10.02 US

10 June 2004 Application Open to Public Inspection

  Published as AU-B-2003287077

20 September 2007 Application Accepted

  Published as AU-B-2003287077

17 January 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003287078-Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy

2003287076-Heterocyclic selective androgen receptor modulators and methods of use thereof